West Pharmaceutical Services, Inc. (WST) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $338.65 -0.72%
EPS Growth %: +11.7%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: +11.7%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.38, $0.03 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $346.8 million versus the consensus estimate of $340.9 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- GitLab’s second-quarter revenue jumps 21% as AI demand drives bookings
- Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
